Congress would rather protect the profits of pharmaceutical companies than the health of those addicted to dangerous opioid drugs, says a former head of the DEA responsible for preventing abuse of medications.
Joseph Rannazzisi, former Deputy Assistant Administrator at the U. S. Drug Enforcement Agency, asserts Big Pharma and its lobbyists have a ‘stranglehold’ on legislators in Congress and have engineered the protection of a $9 billion per year industry over the health of American citizens, according to a report from the Guardian.
‘Congress would rather listen to people who had a profit motive rather than a public health and safety motive,’ he said, according to the outlet. ‘As long as the industry has this stranglehold through lobbyists, nothing’s going to change.’
Rannazzisi explained lobbyists have spent millions thwarting legislative and policy efforts to provide guidelines for reducing the prescribing of opioid medications closely related to heroin – and helped limit the DEA’s powers to discipline those who dispense unusually high dosages of the same.
This post was published at The Daily Sheeple on OCTOBER 31, 2016.